{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T06:50:52Z","timestamp":1762325452744,"version":"3.41.2"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010108","name":"Zhongshan Hospital","doi-asserted-by":"publisher","award":["2020ZSLC17"],"award-info":[{"award-number":["2020ZSLC17"]}],"id":[{"id":"10.13039\/501100010108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Skeletal muscle atrophy is the major hallmark of cancer cachexia. The mechanisms underlying muscle wasting remain elusive in cachectic patients. Our research seeks to identify differentially expressed genes (DEGs) between non-cachectic and cachectic cancer patients and elucidate their functions.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We screened the DEGs of skeletal muscle between patients with and without cachexia from microarray data. Biological function of DEGs is analyzed through gene enrichment analysis, while an interaction network is constructed to visualize how genes are related. A Spearman\u2019s correlation analysis demonstrated the clinical significance of DUSP1 related to cancer cachexia. Skeletal muscle samples were collected and histomorphology studies were conducted. Function of DUSP1 on myogenesis was clarified by qPCR, western blotting, and immunofluorescence.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We screened 324 DEGs in skeletal muscle from patients with and without cachexia. The results of the gene enrichment analysis indicated that inflammatory cytokines and immune responses contribute significantly to the pathological condition of cachexia. DUSP1 was one of the key genes in the regulating network. DUSP1 protein and mRNA levels were increased significantly in skeletal muscle tissues from patients with cancer cachexia. DUSP1 expression in cachectic group was found to have negative correlation with SMA, prealbumin and BMI and positive correlation with TNF\u03b1, IL6 and weight loss. Significant changes of myogenesis related genes were observed in myocyte after DUSP1 was overexpressed and knocked down.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In skeletal muscle of cachectic patients, DUSP1 expression was observed to be higher and thus DUSP1 promote muscle atrophy by inhibiting myogenesis. DUSP1 is expected to be a specific target in cancer cachexia for preventing and treating muscle atrophy.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2022.1040112","type":"journal-article","created":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T04:31:35Z","timestamp":1667277095000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["DUSP1 promotes muscle atrophy by inhibiting myocyte differentiation in cachectic patients"],"prefix":"10.3389","volume":"12","author":[{"given":"Xiangyu","family":"Sui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangyu","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guohao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingyang","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12817","article-title":"Biomarkers related to fatty acid oxidative capacity are predictive for continued weight loss in cachectic cancer patients","volume":"12","author":"Catanese","year":"2021","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3829","article-title":"Cancer cachexia: Understanding the molecular basis","volume":"14","author":"Argil\u00e9s","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12917","article-title":"Human pancreatic tumour organoid-derived factors enhance myogenic differentiation","volume":"13","author":"Vaes","year":"2022","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-014-9915-y","article-title":"Skeletal muscle: A brief review of structure and function","volume":"96","author":"Frontera","year":"2015","journal-title":"Calcified Tissue Int"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2016.1181640","article-title":"Cachexia among US cancer patients","volume":"19","author":"Arthur","year":"2016","journal-title":"J Med Econ"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41389-020-00288-6","article-title":"Understanding the common mechanisms of heart and skeletal muscle wasting in cancer cachexia","volume":"10","author":"Rausch","year":"2021","journal-title":"Oncogenesis"},{"key":"B7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1242\/dmm.010389","article-title":"Cellular and molecular mechanisms of muscle atrophy","volume":"6","author":"Bonaldo","year":"2013","journal-title":"Dis Model Mech"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.673618","article-title":"Phosphorylation of dynamin-related protein 1 (DRP1) regulates mitochondrial dynamics and skeletal muscle wasting in cancer cachexia","volume":"9","author":"Mao","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.2014.279406","article-title":"CrossTalk opposing view: The dominant mechanism causing disuse muscle atrophy is proteolysis","volume":"592","author":"Reid","year":"2014","journal-title":"J Physiol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1126\/science.1072682","article-title":"Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases","volume":"298","author":"Johnson","year":"2002","journal-title":"Science"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3858\/emm.2012.44.5.040","article-title":"The mitogen-activated protein kinase phosphatase-1 (MKP-1) gene is a potential methylation biomarker for malignancy of breast cancer","volume":"44","author":"Chen","year":"2012","journal-title":"Exp Mol Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-008-9123-1","article-title":"Dual-specificity MAP kinase phosphatases (MKPs) and cancer","volume":"27","author":"Keyse","year":"2008","journal-title":"Cancer Metastasis Rev"},{"key":"B13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.molonc.2013.08.012","article-title":"Dual specificity phosphatase 1 expression inversely correlates with NF-\u03baB activity and expression in prostate cancer and promotes apoptosis through a p38 MAPK dependent mechanism","volume":"8","author":"Gil-Araujo","year":"2014","journal-title":"Mol Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s10565-021-09665-2","article-title":"MiR-337-3p confers protective effect on facet joint osteoarthritis by targeting SKP2 to inhibit DUSP1 ubiquitination and inactivate MAPK pathway","author":"Jian","year":"2021","journal-title":"Cell Biol Toxicol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.25327","article-title":"Corticosteroid-induced MKP-1 represses pro-inflammatory cytokine secretion by enhancing activity of tristetraprolin (TTP) in ASM cells","volume":"231","author":"Prabhala","year":"2016","journal-title":"J Cell Physiol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11101879","article-title":"The ERG1A k(+) channel is more abundant in rectus abdominis muscle from cancer patients than that from healthy humans","volume":"11","author":"Zampieri","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2016.00472","article-title":"Cancer and chemotherapy contribute to muscle loss by activating common signaling pathways","volume":"7","author":"Barreto","year":"2016","journal-title":"Front Physiol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s13539-014-0141-2","article-title":"Modeling human cancer cachexia in colon 26 tumor-bearing adult mice","volume":"5","author":"Talbert","year":"2014","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0054-2","article-title":"Metastatic cancers promote cachexia through ZIP14 upregulation in skeletal muscle","volume":"24","author":"Wang","year":"2018","journal-title":"Nat Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"C378","DOI":"10.1152\/ajpcell.00021.2022","article-title":"Muscular contraction's therapeutic potential for cancer-induced wasting","volume":"323","author":"Hardee","year":"2022","journal-title":"Am J Physiol Cell Physiol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3390\/metabo11080517","article-title":"Metabolic remodeling in skeletal muscle atrophy as a therapeutic target","volume":"11","author":"Renzini","year":"2021","journal-title":"Metabolites"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21228592","article-title":"Cachexia, a systemic disease beyond muscle atrophy","volume":"21","author":"Wyart","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13133285","article-title":"Control of skeletal muscle atrophy associated to cancer or corticosteroids by ceramide kinase","volume":"13","author":"Pierucci","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.16820","article-title":"MRTF-a regulates myoblast commitment to differentiation by targeting PAX7 during muscle regeneration","volume":"25","author":"Song","year":"2021","journal-title":"J Cell Mol Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-012-1041-2","article-title":"Diversity and specificity of the mitogen-activated protein kinase phosphatase-1 functions","volume":"70","author":"Lawan","year":"2013","journal-title":"Cell Mol Life Sci"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10091351","article-title":"Dual-specificity phosphatase 1 (DUSP1) has a central role in redox homeostasis and inflammation in the mouse cochlea","volume":"10","author":"Berm\u00fadez-Mu\u00f1oz","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00033.2011","article-title":"Estrogen-related receptor \u03b1 regulates skeletal myocyte differentiation via modulation of the ERK MAP kinase pathway","volume":"301","author":"Murray","year":"2011","journal-title":"Am J Physiol Cell Physiol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12885","article-title":"Ovarian cancer ascites induces skeletal muscle wasting in vitro and reflects sarcopenia in patients","volume":"13","author":"Ubachs","year":"2021","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2013.05.035","article-title":"Molecular mechanisms and signaling pathways of angiotensin II-induced muscle wasting: potential therapeutic targets for cardiac cachexia","volume":"45","author":"Yoshida","year":"2013","journal-title":"Int J Biochem Cell Biol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.1040112\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T04:31:39Z","timestamp":1667277099000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.1040112\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,1]]},"references-count":29,"alternative-id":["10.3389\/fonc.2022.1040112"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2022.1040112","relation":{},"ISSN":["2234-943X"],"issn-type":[{"type":"electronic","value":"2234-943X"}],"subject":[],"published":{"date-parts":[[2022,11,1]]},"article-number":"1040112"}}